94 related articles for article (PubMed ID: 24330150)
1. A systematic analysis of commonly used antibodies in cancer diagnostics.
Gremel G; Bergman J; Djureinovic D; Edqvist PH; Maindad V; Bharambe BM; Khan WA; Navani S; Elebro J; Jirström K; Hellberg D; Uhlén M; Micke P; Pontén F
Histopathology; 2014 Jan; 64(2):293-305. PubMed ID: 24330150
[TBL] [Abstract][Full Text] [Related]
2. Antigen retrieval and primary antibody type affect sensitivity but not specificity of CD117 immunohistochemistry.
Wong NA; Melegh Z
Histopathology; 2009 Apr; 54(5):529-38. PubMed ID: 19413635
[TBL] [Abstract][Full Text] [Related]
3. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.
Novelli M; Rossi S; Rodriguez-Justo M; Taniere P; Seddon B; Toffolatti L; Sartor C; Hogendoorn PC; Sciot R; Van Glabbeke M; Verweij J; Blay JY; Hohenberger P; Flanagan A; Dei Tos AP
Histopathology; 2010 Aug; 57(2):259-70. PubMed ID: 20716168
[TBL] [Abstract][Full Text] [Related]
4. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study.
Dragomir A; de Wit M; Johansson C; Uhlen M; Pontén F
Am J Clin Pathol; 2014 May; 141(5):630-8. PubMed ID: 24713733
[TBL] [Abstract][Full Text] [Related]
5. Concordance of ATM (ataxia telangiectasia mutated) immunohistochemistry between biopsy or metastatic tumor samples and primary tumors in gastric cancer patients.
Kim HS; Kim MA; Hodgson D; Harbron C; Wellings R; O'Connor MJ; Womack C; Yin X; Bang YJ; Im SA; Lee BL; Kim WH
Pathobiology; 2013; 80(3):127-37. PubMed ID: 23328638
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma.
Betta PG; Magnani C; Bensi T; Trincheri NF; Orecchia S
Arch Pathol Lab Med; 2012 Mar; 136(3):253-61. PubMed ID: 22372901
[TBL] [Abstract][Full Text] [Related]
7. How shall we apply the new biology to diagnostics in surgical pathology?
Jones D; Fletcher CD
J Pathol; 1999 Jan; 187(1):147-54. PubMed ID: 10341715
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry in surgical pathology. The case of the undifferentiated malignant neoplasm.
Linder J
Clin Lab Med; 1990 Mar; 10(1):59-76. PubMed ID: 2184980
[TBL] [Abstract][Full Text] [Related]
9. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
[TBL] [Abstract][Full Text] [Related]
10. Newly available antibodies with practical applications in surgical pathology.
Chan JK
Int J Surg Pathol; 2013 Dec; 21(6):553-72. PubMed ID: 24225578
[TBL] [Abstract][Full Text] [Related]
11. Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer.
Zlobec I; Günthert U; Tornillo L; Iezzi G; Baumhoer D; Terracciano L; Lugli A
Histopathology; 2009 Nov; 55(5):564-75. PubMed ID: 19912362
[TBL] [Abstract][Full Text] [Related]
12. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of metastatic neoplasms of the central nervous system.
Becher MW; Abel TW; Thompson RC; Weaver KD; Davis LE
J Neuropathol Exp Neurol; 2006 Oct; 65(10):935-44. PubMed ID: 17021398
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ
Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
[TBL] [Abstract][Full Text] [Related]
15. [The search for better markers for prostate cancer than prostate-specific antigen].
Schenk-Braat EA; Bangma CH
Ned Tijdschr Geneeskd; 2006 Jun; 150(23):1286-90. PubMed ID: 16821452
[TBL] [Abstract][Full Text] [Related]
16. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
17. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
[TBL] [Abstract][Full Text] [Related]
18. [Tumor markers. Their current diagnostic status].
Kudlacek S
Wien Med Wochenschr; 1988 May; 138(10):228-42. PubMed ID: 3043919
[TBL] [Abstract][Full Text] [Related]
19. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
